Business Context and Reporting Period
Company: AngioDynamics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 5, 2016
Reporting Period: Fiscal First Quarter ended August 31, 2016
This filing serves as a notification that the Company issued a press release on October 5, 2016, announcing financial results for the fiscal first quarter. The detailed financial data is contained in the attached press release (Exhibit 99.1) and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Financial Metrics
The provided text is a cover document for the Form 8-K and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being available in the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms the announcement of results for the quarter ended August 31, 2016.
Guidance, Outlook, and Risks
Forward-Looking Statements: The document includes a standard disclaimer regarding forward-looking statements. These statements cover expected future financial position, results of operations, cash flows, business strategy, and growth opportunities.
Key Risks and Uncertainties: The filing lists numerous factors that could cause actual results to differ from expectations, including:
- Ability to develop existing and new products.
- Technological advances and patents by competitors.
- Intellectual property infringement claims.
- Competition from entities with greater resources.
- Regulatory actions by the FDA or other agencies.
- Health care reforms and government regulations.
- Results of pending or future clinical trials.
- Overall economic conditions and foreign currency exchange rate fluctuations.
- Product recalls and product liability claims.
- Changes in key personnel and integration of purchased businesses.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific revenue, earnings, and cash flow figures for the quarter ended August 31, 2016.
- Verify the Company's guidance and outlook statements within the press release, noting they are subject to the risks outlined in this 8-K.
- Check the most recent Form 10-K (year ended May 31, 2016) and Form 10-Q (period ended August 31, 2016) for detailed risk factors and historical financial context.
- Confirm any updates regarding pending litigation, clinical trial results, or regulatory actions mentioned in the risk factors.